Related Experiment Video
Updated: Mar 30, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Gene Network Rewiring to Study Melanoma Stage Progression and Elements Essential for Driving Melanoma
Abhinav Kaushik1, Yashuma Bhatia1, Shakir Ali2
1Bioinformatics Laboratory, Structural and Computational Biology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, 110067, India.
Abstract:
Metastatic melanoma patients have a poor prognosis, mainly attributable to the underlying heterogeneity in melanoma driver genes and altered gene expression profiles. These characteristics of melanoma also make the development of drugs and identification of novel drug targets for metastatic melanoma a daunting task. Systems biology offers an alternative approach to re-explore the genes or gene sets that display dysregulated behaviour without being differentially expressed. In this study, we have performed systems biology studies to enhance our knowledge about the conserved property of disease genes or gene sets among mutually exclusive datasets representing melanoma progression. We meta-analysed 642 microarray samples to generate melanoma reconstructed networks representing four different stages of melanoma progression to extract genes with altered molecular circuitry wiring as compared to a normal cellular state. Intriguingly, a majority of the melanoma network-rewired genes are not differentially expressed and the disease genes involved in melanoma progression consistently modulate its activity by rewiring network connections. We found that the shortlisted disease genes in the study show strong and abnormal network connectivity, which enhances with the disease progression. Moreover, the deviated network properties of the disease gene sets allow ranking/prioritization of different enriched, dysregulated and conserved pathway terms in metastatic melanoma, in agreement with previous findings. Our analysis also reveals presence of distinct network hubs in different stages of metastasizing tumor for the same set of pathways in the statistically conserved gene sets. The study results are also presented as a freely available database at http://bioinfo.icgeb.res.in/m3db/. The web-based database resource consists of results from the analysis presented here, integrated with cytoscape web and user-friendly tools for visualization, retrieval and further analysis.
Insights
Metastatic melanoma progression involves complex gene rewiring, not just differential expression. This study reveals conserved network alterations and identifies key disease genes, aiding in understanding melanoma heterogeneity and potential drug targets.
Area of Science:
- Genomics
- Systems Biology
- Bioinformatics
Background:
- Metastatic melanoma presents a poor prognosis due to genetic heterogeneity and altered gene expression.
- Developing targeted therapies for metastatic melanoma is challenging.
- Systems biology can identify dysregulated genes not detected by differential expression analysis.
Purpose of the Study:
- To explore conserved properties of disease genes and gene sets across melanoma progression using systems biology.
- To identify genes with altered molecular circuitry in melanoma compared to normal states.
- To enhance understanding of metastatic melanoma pathogenesis.
Main Methods:
- Meta-analysis of 642 microarray samples to generate melanoma progression networks.
- Identification of genes with altered network wiring using systems biology approaches.
- Analysis of network connectivity and properties of disease gene sets.
Main Results:
- A majority of melanoma-rewired genes are not differentially expressed.
- Disease genes modulate melanoma progression through network rewiring, with enhanced connectivity during progression.
- Distinct network hubs emerge in different metastatic stages for conserved pathways.
- A freely available database (http://bioinfo.icgeb.res.in/m3db/) of results was created.
Conclusions:
- Conserved network rewiring, rather than just differential gene expression, is crucial in metastatic melanoma.
- Network properties of disease genes offer insights into melanoma progression and potential therapeutic strategies.
- The developed database provides a valuable resource for further melanoma research and drug target identification.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Non-Canonical Wnt Signaling Pathways

